Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HA
2576
DELISTED
Hawaiian Holdings, Inc.
HA
| $5.31M | ﹤0.01% |
493,101
-143,924
| -23% | -$1.25M |
|
2577
Materion
MTRN
$5.13B
| $5.3M | ﹤0.01% |
46,441
-10,789
| -19% | -$1.17M |
|
2578
iShares Core MSCI EAFE ETF
IEFA
$195B
| $5.27M | ﹤0.01% |
78,030
-37,171
| -32% | -$2.52M |
|
2579
Excelerate Energy
EE
$1.24B
| $5.26M | ﹤0.01% |
258,670
-24,181
| -9% | -$505K |
|
2580
Sumitomo Mitsui Financial
SMFG
$161B
| $5.26M | ﹤0.01% |
611,130
+274,518
| +82% | +$2.27M |
|
2581
A10 Networks
ATEN
$1.96B
| $5.25M | ﹤0.01% |
360,091
-227,349
| -39% | -$3.29M |
|
2582
Forestar Group
FOR
$1.46B
| $5.25M | ﹤0.01% |
+232,875
| New | +$4.48M |
|
|
NVEI
2583
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $5.24M | ﹤0.01% |
177,206
-449,382
| -72% | -$15.8M |
|
2584
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.9B
| $5.24M | ﹤0.01% |
78,800
+1,100
| +1% | +$73.5K |
|
2585
Invesco Senior Loan ETF
BKLN
$6.78B
| $5.23M | ﹤0.01% |
248,798
-129,206
| -34% | -$2.69M |
|
2586
Integra LifeSciences
IART
$1.31B
| $5.23M | ﹤0.01% |
127,141
+74,785
| +143% | +$3.6M |
|
2587
LXP Industrial Trust
LXP
$3.6B
| $5.22M | ﹤0.01% |
107,005
+82,714
| +341% | +$4.09M |
|
2588
CALL
BridgeBio Pharma
BBIO
$15.4B
| $5.21M | ﹤0.01% |
302,700
+199,900
| +194% | +$3.01M |
|
2589
Health Catalyst
HCAT
$120M
| $5.21M | ﹤0.01% |
416,499
-1,178,776
| -74% | -$14M |
|
2590
Manulife Financial
MFC
$71.6B
| $5.2M | ﹤0.01% |
275,161
-50,127
| -15% | -$957K |
|
2591
CALL
Dentsply Sirona
XRAY
$2.2B
| $5.2M | ﹤0.01% |
130,000
+70,000
| +117% | +$2.78M |
|
2592
PUT
TripAdvisor
TRIP
$1.15B
| $5.19M | ﹤0.01% |
315,000
-500
| -0.2% | -$8.46K |
|
2593
iShares S&P 500 Value ETF
IVE
$50.2B
| $5.19M | ﹤0.01% |
32,211
+16,385
| +104% | +$2.52M |
|
|
ZING
2594
DELISTED
FTAC Zeus Acquisition Corp. Class A Common Stock
ZING
| $5.19M | ﹤0.01% |
498,030
-9,382
| -2% | -$97K |
|
2595
Assured Guaranty
AGO
$3.34B
| $5.19M | ﹤0.01% |
93,003
+61,767
| +198% | +$3.28M |
|
2596
Starbucks
SBUX
$122B
| $5.19M | ﹤0.01% |
52,382
-1,184,294
| -96% | -$123M |
|
2597
Nu Skin
NUS
$233M
| $5.18M | ﹤0.01% |
155,977
+137,278
| +734% | +$5.05M |
|
2598
Vanguard Total Bond Market
BND
$162B
| $5.17M | ﹤0.01% |
71,163
+44,607
| +168% | +$3.27M |
|
2599
CorVel
CRVL
$3.51B
| $5.16M | ﹤0.01% |
80,070
+17,358
| +28% | +$1.16M |
|
2600
Li Auto
LI
$11.9B
| $5.14M | ﹤0.01% |
146,330
-465,719
| -76% | -$13.1M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.